Cryoprecipitate: Clinical Trials

13 trials of Cryoprecipitate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 recruiting, 1 terminated, 1 unknown. 7 Phase 3, 3 Phase 2, 2 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 37Completed 5, Recruiting 1, Withdrawn 1
Phase 23Completed 2, Unknown 1
Phase 42Completed 2
Not applicable1Terminated 1

Follow Cryoprecipitate: new trials by email Literature Review of Cryoprecipitate trials Research Report on Cryoprecipitate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery
CSL511 Fibrinogen concentrate (human), Cryoprecipitate - Acquired Fibrinogen Deficiency
Phase 3RecruitingCSL Behring902024-10-012026-10-13
Fibrinogen Early In Severe Trauma StudY II
Fibrinogen Concentrate, Cryoprecipitate - Trauma, Haemorrhagic Shock
Phase 3CompletedAustralian and New Zealand Intensive Care Research Centre9002022-11-212026-09-09
Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients
Fibrinogen, Cryoprecipitate - Pediatric HD, Bleeding
Phase 4CompletedUniversity of Virginia312021-10-262026-03-06
In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)
Fibrinogen Concentrate (FC), Cryoprecipitate - Hemostasis
Phase 3CompletedEmory University362019-08-132024-02-20
Fibrinogen Early In Severe Trauma studY Junior
Fibrinogen Concentrate, Cryoprecipitate - Trauma, Hemorrhage
Phase 2UnknownGold Coast Hospital and Health Service442018-07-012020-06-29
Adjusted Fibrinogen Replacement Strategy
BT524, FFP/Cryo - Bleeding Disorder, Hypofibrinogenemia; Acquired
Phase 3CompletedBiotest2222018-04-032025-06-13
FIBrinogen REplenishment in Surgery
Octafibrin, Cryoprecipitate - Deficiency; Fibrinogen, Acquired
Phase 3CompletedUniversity Health Network, Toronto8272017-02-222019-05-14
Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation
Cryoprecipitate, Red Blood Cells, Plasma - Trauma Injury
Phase 3CompletedBryan Cotton16042017-01-012025-01-14
Fibrinogen Early In Severe Trauma studY
Fibrinogen Concentrate, Cryoprecipitate - Trauma, Haemorrhage
Phase 2CompletedGold Coast Hospital and Health Service1002016-12-012018-03-05
Fibrinogen Concentrate vs Cryoprecipitate
Fibrinogen Concentrate, Cryoprecipitate - Congenital Heart Disease
Phase 4CompletedStanford University602016-03-012019-05-07
Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions
ROTEM, Cryoprecipitate, RiaSTAP - Coagulopathy
Not applicableTerminatedWeill Medical College of Cornell University192015-10-012019-01-15
Fibrinogen Concentrate In Children After Cardiac Surgery
Fibrinogen concentrate, Cryoprecipitate - Cardiac Surgical Procedures, Blood Coagulation Disorders
Phase 2CompletedUniversity of Sao Paulo632010-08-012013-01-04
Fibrinogen Concentrate (Human) - Efficacy and Safety Study
Fibrinogen Concentrate, Human (FCH), Cryoprecipitate - Afibrinogenemia, Hypofibrinogenemia
Phase 3WithdrawnCSL Behring2009-10-012023-02-06

Conditions studied

Hemostatic Disorders (5)  ·  Afibrinogenemia (4)  ·  Hemorrhage (4)  ·  Wounds and Injuries (3)  ·  Blood Coagulation Disorders (2)  ·  Accidental Injuries (1)  ·  Heart Defects, Congenital (1)  ·  Pseudomyxoma Peritonei (1)  ·  Shock, Hemorrhagic (1)

Sponsors

CSL Behring (2)  ·  Gold Coast Hospital and Health Service (2)  ·  Australian and New Zealand Intensive Care Research Centre (1)  ·  Biotest (1)  ·  Bryan Cotton (1)  ·  Emory University (1)  ·  Stanford University (1)  ·  University Health Network, Toronto (1)  ·  University of Sao Paulo (1)  ·  University of Virginia (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (5)  ·  Australia (3)  ·  United Kingdom (3)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Laura Downey, MD (2)  ·  Bryan A Cotton, MD (1)  ·  Glyn D Williams, MBChB, FFA (1)  ·  James Winearls, MBBS (1)  ·  Keita Ikeda, MD (1)  ·  Keyvan Karkouti, MD (1)  ·  Niels Rahe-Meyer, Prof. (1)  ·  Nikolaos J Skubas, M.D. (1)  ·  Shane George, MBBS (1)  ·  Zoe McQuilten, MBBS (1)

Results publications

PMID 28549445, PMID 29678987, PMID 31634905, PMID 35508351, PMID 35773027, PMID 36163263, PMID 37588266, PMID 37824155, PMID 39116012, PMID 40420619, PMID 40741224, PMID 42247815

NIH funding

2017 (1)